Conditions: Low Anterior Resection Syndrome; Rectal Cancer
Intervention: Drug: intra-rectal Botulinum toxin A injection
Sponsors: Centre hospitalier de l'Université de Montréal (CHUM); Centre hospitalier de l'Université de Montréal (CHUM); Allergan
Not yet recruiting - verified June 2011
Feeds
4445 items (4445 unread) in 80 feeds
Acinar Cell Carcinoma
(28 unread)
Acinic Cell Carcinoma
(32 unread)
Adenoid Cystic Carcinoma
(54 unread)
Adrenal Gland Cancer
(324 unread)
Ampulla Of Vater
(13 unread)
Anal Cancer
(250 unread)
Angiosarcoma
(72 unread)
Appendix Cancer
(34 unread)
Bile Duct Cancer
(382 unread)
Brain and CNS
(1106 unread)
Carcinoid
(141 unread)
Endocrine/Neuroendocrine
(272 unread)
Gall Bladder Cancer
(219 unread)
Hemangioendothelioma
(23 unread)
Hepatoblastoma
(30 unread)
Pancreas
(45 unread)
Phyllodes
(18 unread)
PMP and Mucinous Tumors
(16 unread)
Rhabdomyosarcoma
(180 unread)
Sarcoma
(545 unread)
Twitter Pals
(661 unread)
Trial - Anal Cancers (9 unread)
-
The Value of Botox-A for Management of Low Anterior Resection Syndrome
Posted: April 27th, 2012, 8:00am MDT
-
A Phase II Study of Lymphodepletion Followed by Autologous Tumor-Infiltrating Lymphocytes and High-Dose AJdesleukin for HumanPapillomavirus-Associated Cancers
Posted: April 24th, 2012, 8:00am MDT
Conditions: Cervical Cancer; Oropharyngeal Cancer; Vaginal Cancer; Anal Cancer; Penile Cancer
Interventions: Drug: Fluderabine; Drug: Cycolphosphamide; Biological: Young TIL; Biological: Aldesleukin
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting - verified April 2012 -
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Posted: April 6th, 2012, 8:00am MDT
Conditions: Epidermoid Carcinoma; Anus
Interventions: Drug: radiochemotherapy; Drug: Panitumumab
Sponsors: Federation Francophone de Cancerologie Digestive; Federation Francophone de Cancerologie Digestive
Not yet recruiting - verified April 2012 -
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
Posted: March 29th, 2012, 8:00am MDT
Conditions: Anal Cancer; Cervical Cancer; Lung Cancer; Lymphoma; Nonneoplastic Condition
Interventions: Genetic: DNA analysis; Genetic: RNA analysis; Genetic: gene expression analysis; Genetic: polymorphism analysis; Other: biologic sample preservation procedure; Other: flow cytometry; Other: laboratory biomarker analysis; Other: medical chart review
Sponsors: National Cancer Institute (NCI); AIDS Associated Malignancies Clinical Trials Consortium; National Cancer Institute (NCI)
Not yet recruiting - verified March 2012 -
ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy
Posted: September 14th, 2011, 8:00am MDT
Conditions: Colonic Neoplasms; Iron Deficiency Anemia; Diarrhea
Intervention: Device: Olympus ScopeGuide
Sponsors: University of Alberta; Christopher Teshima
Recruiting - verified April 2012 -
Alkagin Paste in the Prevention of Radiation Dermatitis
Posted: August 2nd, 2011, 8:00am MDT
Conditions: Anus Neoplasms; Rectal Neoplasms; Urogenital Neoplasms
Interventions: Other: Aveeno cream; Other: Alkagin paste
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Dr. Te Vuong; Avario Healthcare
Recruiting - verified May 2012 -
Nimotuzumab With Radiotherapy in the Treatment of Anal Canal Cancers
Posted: June 24th, 2011, 8:00am MDT
Condition: Squamous Cell Carcinoma of Anal Canal
Interventions: Drug: Nimotuzumab; Radiation: Intensity Modulated Radiation Therapy (IMRT)
Sponsors: Sir Mortimer B. Davis - Jewish General Hospital; Dr. Te Vuong; YM BioSciences
Recruiting - verified May 2012 -
Indocyanine Green Fluorescent Molecular Imaging of the Gastrointestinal Tract
Posted: April 27th, 2010, 8:00am MDT
Conditions: High Risk Polyposis Syndrome; Distal Colonic Lesions; Colorectal Polyps
Intervention: Drug: indocyanine green
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; Dana-Farber Cancer Institute; National Cancer Institute (NCI); Damon Runyon Cancer Research Foundation
Recruiting - verified April 2012 -
UCN-01 and Irinotecan in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple-Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
Posted: March 8th, 2002, 8:00am MST
Condition: Cancer
Interventions: Drug: 7-hydroxystaurosporine; Drug: irinotecan hydrochloride; Other: laboratory biomarker analysis
Sponsors: National Cancer Institute (NCI); University of Virginia; National Cancer Institute (NCI); Washington University Siteman Cancer Center
Completed - verified August 2009